In diabetes and NAFLD (Biddinger et al., 2008; Chen et al., 2016), reduced hepatic CYP7B1 expression has been reported, suggesting a role of the alternative pathway for metabolic homeostasis in humans. Here, CYP7B1 is linked to metabolic dysfunction-associated steatotic liver disease.